Zachary J. Williams
M.D./Ph.D. student
Vanderbilt University
From this contributor
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
A new hub for participatory research: Q&A with Zachary Williams
Last month, the International Society for Autism Research launched the INSAR Community Collaborator Request (ICCR), an online forum to foster collaborations between autistic people and autism researchers. Its creator, Zachary Williams, explains how researchers can make the most of this new resource.
A new hub for participatory research: Q&A with Zachary Williams
Measuring alexithymia in autistic people
Despite the growing interest in alexithymia in autism research, the tools commonly used to measure this trait may not work reliably in autistic populations. A new scoring method fills that gap.
Measuring alexithymia in autistic people
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”